$171 Million is the total value of Osher Van de Voorde Investment Management's 27 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SCHW | Exit | Charles Schwab Corp | $0 | – | -204,175 | -100.0% | -3.84% | – |
| TEVA | Exit | Teva Pharmaceuticals ADRadr | $0 | – | -128,950 | -100.0% | -4.44% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Berkshire Hathaway Inc-Del Cl B | 42 | Q3 2023 | 5.7% |
| Apple Computer Inc | 42 | Q3 2023 | 5.9% |
| J P Morgan Chase & Co | 42 | Q3 2023 | 5.3% |
| Pepsico Inc | 42 | Q3 2023 | 5.3% |
| Microsoft Corp | 42 | Q3 2023 | 5.3% |
| Visa Inc. | 42 | Q3 2023 | 5.4% |
| Qualcomm Inc | 42 | Q3 2023 | 6.8% |
| United Parcel Service Inc. | 42 | Q3 2023 | 5.2% |
| Johnson & Johnson | 42 | Q3 2023 | 5.4% |
| Canadian National Railway Co | 42 | Q3 2023 | 4.8% |
View Osher Van de Voorde Investment Management's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-09 |
| 13F-HR | 2024-01-09 |
| 13F-HR | 2023-10-10 |
| 13F-HR | 2023-07-24 |
| 13F-HR | 2023-04-11 |
| 13F-HR | 2023-01-13 |
| 13F-HR | 2022-10-05 |
| 13F-HR | 2022-07-19 |
| 13F-HR | 2022-04-14 |
| 13F-HR | 2022-01-10 |
View Osher Van de Voorde Investment Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.